A new randomized clinical trial found that men with localized, intermediate‑risk prostate cancer recovered faster and ...

This may also help explain why coupled men statistically trend toward living ...

Prostate cancer has long frustrated immunologists. Checkpoint inhibitors that unleash the immune system against tumors in the ...

Six-time Olympic gold medalist Sir Chris Hoy recently revealed he has terminal prostate cancer. Amid Hoy’s diagnosis, experts are urging men to keep an eye out for an easy-to-miss sign of prostate ...

HealthDay News — For men with locally advanced prostate cancer, transdermal estradiol (tE2) patches are noninferior to ...

A common diabetes drug may mimic one key effect of exercise in prostate cancer patients. Researchers found metformin boosts an “exercise molecule” linked to appetite and weight control, even in those ...

The main advantage of proton therapy is its precision. Protons deposit most of their energy directly in the tumor with little ...

More than 35,000 men in the United States die from prostate cancer each year. Now, a new study reveals the immune cell ...

There may be a "promising new strategy" in combating aggressive forms of prostate cancer, according to a new study. Researchers at Flinders University and the University of South Australia ...

An MRI before treatment in men undergoing radical prostatectomy can provide independent prognostic value for oncologic ...

The addition of the AKT inhibitor capivasertib (Truqap) to abiraterone (Zytiga) and androgen deprivation therapy (ADT) ...

A newly expanded prostate cancer drug could bring new hope to patients with a common form of the disease. Novartis, a Switzerland-based pharmaceutical company, announced on March 28 that the U.S. Food ...